Renata Talar-Wojnarowska Selected Research

Renata Talar-Wojnarowska Research Topics

Disease

11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 09/2006
10	Neoplasms (Cancer) 05/2021 - 03/2009
8	Chronic Pancreatitis 01/2018 - 01/2005
7	Adenocarcinoma 08/2016 - 01/2005
6	Crohn Disease (Crohn's Disease) 01/2021 - 01/2015
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2021 - 01/2020
4	Carcinogenesis 07/2013 - 06/2002
3	Ulcerative Colitis 11/2021 - 01/2021
3	Pain (Aches) 01/2021 - 07/2013
3	Disease Progression 01/2021 - 03/2011
3	Pancreatic Diseases (Pancreatic Disease) 11/2015 - 04/2013
3	Adenoma (Adenomas) 01/2014 - 05/2009
3	Polyps 01/2014 - 05/2009
2	Autoimmune Pancreatitis 01/2018 - 09/2014
2	Neoplasm Metastasis (Metastasis) 07/2013 - 03/2009
2	Pancreatic Cyst 02/2013 - 09/2012
2	Adenomatous Polyps 01/2013 - 05/2009
1	Collagenous Colitis 05/2021
1	Ischemic Colitis 05/2021
1	Amyloidosis 05/2021
1	Sleep Wake Disorders 01/2021
1	Pneumonia (Pneumonitis) 01/2020
1	Exocrine Pancreatic Insufficiency 01/2018
1	Inflammation (Inflammations) 01/2014
1	Pancreatitis 03/2011
1	Carcinoma (Carcinomatosis) 05/2009
1	Infections 05/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2014
3	CytokinesIBA 08/2016 - 06/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017 - 01/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2014 - 03/2009
2	EnzymesIBA 06/2013 - 04/2013
2	Carcinoembryonic AntigenIBA 02/2013 - 09/2012
1	tofacitinibIBA 11/2021
1	Indicators and Reagents (Reagents)IBA 10/2021
1	Amyloid (Amyloid Fibrils)IBA 05/2021
1	Proteins (Proteins, Gene)FDA Link 05/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	vedolizumabIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	IntegrinsIBA 01/2021
1	antithrombin III-protease complexIBA 12/2020
1	P-SelectinIBA 12/2020
1	SelectinsIBA 12/2020
1	Thromboplastin (Tissue Factor)IBA 12/2020
1	Adalimumab (Humira)FDA Link 10/2020
1	Mesalamine (Mesalazine)FDA LinkGeneric 01/2020
1	erucylphosphocholineIBA 01/2019
1	Tumor Necrosis Factor InhibitorsIBA 10/2017
1	RE1-silencing transcription factorIBA 12/2016
1	DNA (Deoxyribonucleic Acid)IBA 12/2016
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2016
1	telomerase RNA (bTR)IBA 11/2015
1	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2015
1	Immunoglobulin G (IgG)IBA 09/2014
1	AntibodiesIBA 09/2014
1	Carbonic Anhydrase IIIBA 09/2014
1	C-Reactive ProteinIBA 01/2014
1	ResistinIBA 07/2013
1	Nicotinamide PhosphoribosyltransferaseIBA 07/2013
1	LeptinIBA 07/2013
1	AdipokinesIBA 07/2013
1	Peptide Hydrolases (Proteases)FDA Link 06/2013
1	Tissue Inhibitor of Metalloproteinase-1IBA 06/2013
1	Tissue Inhibitor of Metalloproteinase-2IBA 06/2013
1	Blood Group Antigens (Blood Groups)IBA 04/2013
1	GlycosyltransferasesIBA 04/2013
1	Amylases FDA Link 02/2013
1	CarbohydratesIBA 02/2013
1	AntigensIBA 02/2013
1	Insulin-Like Growth Factor Binding Protein 3IBA 01/2013
1	Insulin-Like PeptidesIBA 01/2013
1	Insulin (Novolin)FDA Link 01/2013
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 09/2011
1	TrypsinogenIBA 03/2011
1	Kazal Pancreatic Trypsin InhibitorIBA 03/2011
1	tissue polypeptide specific antigenIBA 01/2010
1	NeopterinIBA 01/2010
1	Peptide Hormones (Polypeptide Hormones)IBA 05/2009
1	GastrinsIBA 05/2009
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2002

Therapy/Procedure

4	Therapeutics 01/2021 - 10/2017
2	Biological Therapy 11/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2020 - 09/2006
2	Pancreatectomy 07/2006 - 01/2005
1	Duration of Therapy 10/2020
1	Conservative Treatment 01/2018
1	Gastric Balloon 01/2015
1	Bariatric Surgery 01/2015